產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
201362-100MG |
|
2357080-07-8 |
(S)-4-((3,6-二(4-甲氧基苯基)-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Bis(4-methoxyphenyl)-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C31H28N2O3 | |
201361-100MG |
|
2357080-04-5 |
(S)-4-((3,6-二(4-(三氟甲基)苯基)-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Bis(4-(trifluoromethyl)phenyl)-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C31H22F6N2O | |
201360-100MG |
|
2357080-05-6 |
(S)-4-((3,6-二(3,5-二(三氟甲基)苯基)-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Bis(3,5-bis(trifluoromethyl)phenyl)-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C33H20F12N2O | |
201359-100MG |
|
2357080-03-4 |
(S)-4-((3,6-二(3-(三氟甲基)苯基)-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Bis(3-(trifluoromethyl)phenyl)-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C31H22F6N2O | |
201358-100MG |
|
2357080-02-3 |
(S)-4-((3,6-二苯-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Diphenyl-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C29H24N2O | |
201357-100MG |
|
2357080-01-2 |
(S)-4-((7H-二苯并[c,g]咔唑-7-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((7H-Dibenzo[c,g]carbazol-7-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C25H20N2O | |
201356-100MG |
|
2357080-00-1 |
(S)-4-((7H-苯并[c]咔唑-7-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((7H-Benzo[c]carbazol-7-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C21H18N2O | |
201355-100MG |
|
2357079-98-0 |
(S)-4-((3,6-二叔丁基-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Di-tert-butyl-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C25H32N2O | |
201354-100MG |
|
2357079-97-9 |
(S)-4-((3,6-二碘-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Diiodo-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C17H14I2N2O | |
201353-100MG |
|
2357079-96-8 |
(S)-4-((3,6-二溴-9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((3,6-Dibromo-9H-carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C17H14Br2N2O | |
201352-100MG |
|
2357079-95-7 |
(S)-4-((9H-咔唑-9-基)甲基)-2-甲基-4,5-二氫惡唑 (S)-4-((9H-Carbazol-9-yl)methyl)-2-methyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C17H16N2O | |
201369-100MG |
|
2195357-80-1 |
(S)-4-((1-(3,5-二(三氟甲基)苯基)-1H-吲哚-3-基)甲基)-2-甲基-5,5-二苯-4,5-二氫惡唑 (S)-4-((1-(3,5-Bis(trifluoromethyl)phenyl)-1H-indol-3-yl)methyl)-2-methyl-5,5-diphenyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C33H24F6N2O | |
201368-100MG |
|
2195357-79-8 |
(S)-4-((1-(3,5-二(三氟甲基)苯基)-1H-吲哚-3-基)甲基)-2,5,5-三甲基-4,5-二氫惡唑 (S)-4-((1-(3,5-Bis(trifluoromethyl)phenyl)-1H-indol-3-yl)methyl)-2,5,5-trimethyl-4,5-dihydrooxazole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C23H20F6N2O | |
201351-100MG |
|
2195357-78-7 |
1-[3,5-二(三氟甲基)苯]-3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1H-吲哚 1-[3,5-Bis(trifluoromethyl)phenyl]-3-[[(4S)-4,5-dihydro-2-methyl-4-oxazolyl]methyl]-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C21H16F6N2O | |
201350-100MG |
|
2195357-77-6 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-[3-(三氟甲基)苯基]-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-[3-(trifluoromethyl)phenyl]-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C20H17F3N2O | |
201349-100MG |
|
2195357-76-5 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-(4-甲氧基苯基)-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-(4-methoxyphenyl)-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C20H20N2O2 | |
201348-100MG |
|
2195357-75-4 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-(2,3,4,5,6-五氟苯基)-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C19H13F5N2O | |
201347-100MG |
|
2195357-74-3 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-苯基-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-phenyl-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C19H18N2O | |
201346-100MG |
|
2195357-73-2 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-異丙基-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-(1-methylethyl)-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C16H20N2O | |
201345-100MG |
|
2195357-72-1 |
3-[[(4S)-4,5-二氫-2-甲基-4-惡唑基]甲基]-1-甲基-1H-吲哚 3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1-methyl-1H-indole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C14H16N2O | |